Vivex Biologics Announces Publication of a Real-World Evidence Study Demonstrating Superior or Similar Outcomes for Cygnus(R) Amnion-Based Skin Substitutes in Wound Care GlobeNewswire November 13, 2025 MIAMI, Nov. 13, 2025 (GLOBE NEWSWIRE) — Vivex Biologics, Inc., a leading medical technology company, developing and delivering innovative allografts for musculoskeletal and wound-care applications, today announced the publication […]

Cingulate Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire November 13, 2025 Industry Veteran Bryan Downey Named Chief Commercial Officer NDA Accepted with May 2026 PDUFA Date Commercial Supply Agreement Executed KANSAS CITY, Kan., Nov. 13, 2025 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision

Rocklinc Investment Partners Inc. Announces Rocklinc Principled Equity ETF Listing on the TSX GlobeNewswire November 13, 2025 BURLINGTON, Ontario, Nov. 13, 2025 (GLOBE NEWSWIRE) — Rocklinc Investment Partners Inc. (“Rocklinc”) is pleased to announce the listing of units of Rocklinc Principled Equity ETF (the “ETF”) on the Toronto Stock Exchange (“TSX”). Units of the ETF

City of Ottawa's OC Transpo Orders 50 New Flyer Xcelsior(R) Clean-Diesel 60-foot Buses GlobeNewswire November 13, 2025 WINNIPEG, Manitoba, Nov. 13, 2025 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) Today, NFI Group Inc.'s (NFI) subsidiary, New Flyer Industries Canada ULC (New Flyer), announced an order from OC Transpo (City of Ottawa) for 50

MIMEDX Provides Update on EPIEFFECT(R) Randomized Controlled Trial GlobeNewswire November 13, 2025 Publication of Interim Results and Presentation at Recent Industry Event Demonstrate Clinical Benefit Associated with Use of EPIEFFECT When Compared to Standard of Care (“SOC”) Publication Adds to Large Compendium of Evidence for MIMEDX's Leading Product Portfolio Trial Enrollment Ongoing MARIETTA, Ga., Nov.

LiqTech International Announces Third Quarter 2025 Financial Results GlobeNewswire November 13, 2025 BALLERUP, Denmark, Nov. 13, 2025 (GLOBE NEWSWIRE) — LiqTech International, Inc. (Nasdaq: LIQT) (“LiqTech”), a clean technology company that manufactures and markets highly specialized filtration technologies, today announced its financial results for the third quarter of 2025 for the period ended September 30,

Byrna Technologies Sets Upcoming Investor Conference Schedule GlobeNewswire November 13, 2025 ANDOVER, Mass., Nov. 13, 2025 (GLOBE NEWSWIRE) — Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security solutions, is scheduled to participate at the following financial conferences

GenoSafe strengthens its leadership in analytical expertise with the opening of new GMP-compliant laboratories to support the advanced therapies sector GlobeNewswire November 13, 2025 GenoSafe strengthens its leadership in analytical expertise with the opening of new GMP-compliant laboratories to support the advanced therapies sector Evry-Courcouronnes, France, November 16th, 2025 – GenoSafe, the French Contract Research

Matisse Pharmaceuticals successfully completes study with prolonged infusion of M6229 in healthy volunteers GlobeNewswire November 13, 2025 Geleen, November 13th, 2025. Matisse Pharmaceuticals B.V., a clinical stage company developing a medicinal product for the treatment of sepsis, today announced top line results from its phase 1 study evaluating the safety, tolerability & pharmacokinetics of a

Arcutis Completes Enrollment in INTEGUMENT-INFANT Phase 2 Study Evaluating ZORYVE(R) (roflumilast) Cream 0.05% in Infants with Atopic Dermatitis GlobeNewswire November 13, 2025 Investigational ZORYVE cream 0.05% was formulated for the delicate skin of infants and young children with mild to moderate atopic dermatitis Topline results anticipated in Q1 2026 The U.S. FDA approved ZORYVE cream